How Many Patients Will Benefit From a New Therapy for Chronic Systolic Heart Failure, and What Difference Does it Make?

被引：2
|
作者：
Borer, Jeffrey S. [1 ,2 ,3 ,4 ]
机构：
[1] Suny Downstate Med Ctr, Howard Gilman Inst Heart Valve Dis, Div Cardiovasc Med, Brooklyn, NY 11203 USA
[2] Suny Downstate Med Ctr, Schiavone Inst Cardiovasc Translat Res, Brooklyn, NY 11203 USA
[3] Suny Downstate Med Ctr, Howard Gilman Inst Heart Valve Dis, Div Cardiovasc Med, New York, NY 10128 USA
[4] Suny Downstate Med Ctr, Schiavone Inst Cardiovasc Translat Res, New York, NY 10128 USA
来源：
JACC-HEART FAILURE | 2015年 / 3卷 / 03期
关键词：
f-channels; heart rate reduction; myocardial function; RATE REDUCTION; OUTCOMES; SHIFT; ASSOCIATION; IVABRADINE; FORCE; CARE;
D O I：
10.1016/j.jchf.2014.12.007
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：231 / 233
页数：3
相关论文
共 50 条
  • [1] Does Thermal Therapy Benefit Patients With Chronic Heart Failure? Reply
    Ramani, Gautam V.
    Uber, Patricia A.
    Mehra, Mandeep R.
    MAYO CLINIC PROCEEDINGS, 2010, 85 (07) : 693 - 693
  • [2] How many patients with systolic heart failure patients have an indication for ivabradine?
    Balestrieri, G.
    Russell, K.
    Mcinnes, N.
    Mcmurray, J. J. V.
    EUROPEAN JOURNAL OF HEART FAILURE, 2013, 12 : S184 - S184
  • [3] Prognostic importance of cognitive impairment in chronic heart failure patients: Does specialist management make a difference?
    McLennan, Skye N.
    Pearson, Sue A.
    Cameron, Janette
    Stewart, Simon
    EUROPEAN JOURNAL OF HEART FAILURE, 2006, 8 (05) : 494 - 501
  • [4] Prescribing for chronic heart failure in Europe: does the country make the difference? A European survey
    Sturm, H. B.
    van Gilst, W. H.
    Veeger, N.
    Haaijer-Ruskamp, F. M.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 (01) : 96 - 103
  • [5] Low cost educational intervention in heart failure patients - does it make difference?
    Rywik, T.
    Kolodziej, P.
    Targonski, R.
    Fedyk-Lukasik, M.
    Nowicka, A.
    Zbyszynski, B.
    Achremczyk, P.
    Gorski, J.
    Leszek, P.
    Korewicki, J.
    EUROPEAN HEART JOURNAL, 2010, 31 : 1046 - 1047
  • [6] Does eplerenone benefit postinfarction patients with heart failure and left ventricular systolic dysfunction?
    Aldo Pietro Maggioni
    Nature Clinical Practice Cardiovascular Medicine, 2005, 2 : 618 - 619
  • [7] Influence of pretreatment systolic blood pressure on benefit from carvedilol in severe chronic heart failure patients
    Ghali, JK
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (05) : 809 - 809
  • [8] The effects of chronic sildenafil therapy in patients with stable systolic heart failure
    Thomas, R.
    Fisher, J.
    Heppel, R.
    Brayshaw, N.
    Cluck, S.
    Gilbert, C.
    Butrous, G.
    Kamalvand, K.
    EUROPEAN HEART JOURNAL, 2008, 29 : 508 - 508
  • [9] Cardiac resynchronization therapy in asymptomatic and mildly symptomatic chronic systolic heart failure: A new era of systolic heart failure management?
    Kourouklis, Spyros P.
    Manolis, Athanasios G.
    HELLENIC JOURNAL OF CARDIOLOGY, 2008, 49 (05) : 349 - 351
  • [10] Transition from diastolic heart failure to systolic heart failure does not affect the prognosis of patients
    Jun, T
    Tsuyoshi, S
    Yutaka, K
    Jun, W
    Kunio, S
    JOURNAL OF CARDIAC FAILURE, 2004, 10 (05) : S171 - S171
12345